Compare Perpetua Medical AB with Similar Stocks
Stock DNA
Electronics & Appliances
SEK 29 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.42
6.15%
1.47
Revenue and Profits:
Net Sales:
5 Million
(Quarterly Results - Dec 2025)
Net Profit:
-4 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-30.07%
0%
-30.07%
6 Months
-32.85%
0%
-32.85%
1 Year
-48.23%
0%
-48.23%
2 Years
67.19%
0%
67.19%
3 Years
-93.76%
0%
-93.76%
4 Years
-97.76%
0%
-97.76%
5 Years
-98.35%
0%
-98.35%
Perpetua Medical AB for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
49.49%
EBIT Growth (5y)
6.36%
EBIT to Interest (avg)
-13.91
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.49
Sales to Capital Employed (avg)
0.73
Tax Ratio
5.87%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.55
EV to EBIT
-3.70
EV to EBITDA
-4.55
EV to Capital Employed
4.90
EV to Sales
1.75
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-132.33%
ROE (Latest)
-76.06%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Bearish
Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
5.20
3.50
48.57%
Operating Profit (PBDIT) excl Other Income
-3.40
-2.00
-70.00%
Interest
0.30
0.20
50.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-4.00
7.10
-156.34%
Operating Profit Margin (Excl OI)
-921.30%
-744.00%
-17.73%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 48.57% vs 29.63% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -156.34% vs 1,114.29% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
14.60
6.90
111.59%
Operating Profit (PBDIT) excl Other Income
-7.30
-9.20
20.65%
Interest
0.90
0.10
800.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.20
-2.40
150.00%
Operating Profit Margin (Excl OI)
-672.50%
-1,375.50%
70.30%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 111.59% vs -30.30% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 150.00% vs 86.89% in Dec 2024
About Perpetua Medical AB 
Perpetua Medical AB
Electronics & Appliances
Pharmacolog I Uppsala AB (publ) is a Sweden-based medical device company that specializes in providing quality assurance solutions for safe administration of medical drugs. The company’s main product, DrugLog, focuses on quality assurance in drug administration in the hospital pharmacy and the clinical ward.
Company Coordinates 
Company Details
Ekeby Bruk 2H , UPPSALA None : 752 63
Registrar Details






